KyleLennon
Member
- Messages
- 54
- Likes
- 3
ValuEngine upgraded Cara Therapeutics (CARA).
Cara is evaluating an injection of CR845 in a phase-3 clinical study targeting treatment of chronic kidney disease-associated pruritus (CKD-aP) patients.
How do you think CARA?
Cara is evaluating an injection of CR845 in a phase-3 clinical study targeting treatment of chronic kidney disease-associated pruritus (CKD-aP) patients.
How do you think CARA?